CD19 and POU2AF1 are Potential Immune-Related Biomarkers Involved in the Emphysema of COPD: On Multiple Microarray Analysis.
Da-Wei ZhangJing-Jing YeYing SunShuang JiJia-Ying KangYuan-Yuan WeiGuang-He FeiPublished in: Journal of inflammation research (2022)
CD19 and POU2AF1 may serve as key regulators of emphysema and contribute to the progression of COPD by regulating the B-cell immunology. Targeting B cells may be a promising strategy for treating COPD.